Vitera Launches Institutional Share Class for State Street GTC Retirement Income Builder Target Date Fund Series, Expanding Guaranteed Income to More 401(k) Participants New Share Class Delivers Default-Ready, Fully Liquid Income Solutions to Large- and Mega-Defined Contribution Plans GlobeNewswire October 27, 2025 NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) — Vitera (formerly ARS), the provider […]

NodThera Announces First Patients Dosed in RESOLVE-2 Clinical Trial Evaluating Oral NT-0796 in Combination with a GLP-1 Receptor Agonist GlobeNewswire October 27, 2025 NT-0796 is an oral, brain-penetrant NLRP3 inhibitor that selectively regulates chronic inflammation, a key driver of cardiometabolic diseases Expects to complete the ongoing NT-0796 monotherapy trial (RESOLVE-1) and NT-0796 combination trial with

Enphase Energy Announces Complete Off-Grid Solar and Battery Solution in the U.S. GlobeNewswire October 27, 2025 FREMONT, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced support for complete off-grid system configurations that are

Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers GlobeNewswire October 27, 2025 New diagnostic addresses critical gap in IVF care–measuring whether the uterus is ready to support an embryo Study shows test accurately identifies patients at risk for failed transfers and those with healthy endometrium, enabling personalized treatment decisions HOUSTON,

Centers for Medicare and Medicaid Services Assigns Permanent J Code for ZUSDURI(TM) Effective January 1, 2026 GlobeNewswire October 27, 2025 PRINCETON, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that the Centers for

Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL(R) GlobeNewswire October 27, 2025 BRISBANE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it

Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors GlobeNewswire October 27, 2025 BENTONVILLE, Ark., Oct. 27, 2025 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC) is pleased to announce the appointment of Edmund (Ned) Burke, a highly accomplished financial services executive, to its Board of Directors. With more

Dandy unveils next era of digital dentistry with Dandy Vision intraoral scanner Powered by the nation's most advanced dental lab, Dandy introduces the world's smartest intraoral scanner. Trained on over 10 million scans, it combines incredible speed with AI-powered precision to redefine digital dentistry GlobeNewswire October 27, 2025 NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE)

Registered Investment Advisors See Wire Fraud, AI Errors as Emerging Threats to their Business, According to Golsan Scruggs 2025 Risk Survey Concerns about cyber breaches and regulatory risk and trade errors are among top RIA concerns. GlobeNewswire October 27, 2025 Lake Oswego, Ore., Oct. 27, 2025 (GLOBE NEWSWIRE) — Registered investment advisors (RIAs) are growing

WEBs Investments Announces Name Changes for Defined Volatility(SM) ETFs GlobeNewswire October 27, 2025 PARK CITY, Utah, Oct. 27, 2025 (GLOBE NEWSWIRE) — WEBs Investments Inc. (WEBs), an innovator in volatility-managed investment solutions, today announces updated fund names for its Defined Volatility(SM) ETF suite, effective immediately. The revised names are designed to give investors a clearer